Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1994-10-06
1999-04-06
Walsh, Stephen G.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4353201, 435 697, 536 235, C12N 1512, C12N 1563
Patent
active
058916644
ABSTRACT:
Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type plasminogen activator from converting plasminogen into plasmin. DNA fragments which encode for soluble, active fragments of the urokinase-type plasminogen activator are provided.
REFERENCES:
patent: 4571421 (1986-02-01), Itakura
patent: 5342764 (1994-08-01), Johnson et al.
Ploug, M., et al. (1991) J. Biol. Chem. 266: 1926-33.
Behrendt, N., et al. (1991) ibiol., 7842-47.
Min, H.Y., et al. (1992) J. Immunol. 148:3636-42.
Appella, E., et al., "The Receptor-binding Sequence of Urokinase," J. Biol. Chem., 262(10):4437-4440 (1987).
Bajpai, A., et al., "Cryptic Urokinase Binding Sites on Human Foreskin Fibroblasts," Biochem. Biophys. Res. Commun., 133(2):475-482 (1985).
Blasi, F., "Surface Receptors for Urokinase Plasminogen Activator," Fibrinolysis, 2:73-84 (1988).
Blasi, F., et al., "The Receptor for Urokinase-Plasminogen Activator," J. Cell. Biochem., 32:179-186 (1986).
Blasi, F., et al., "Urokinase-Type Plasminogen Activator: Proenzyme, Receptor, and Inhibitors," J. Cell. Biol., 104:801-807 (1987).
Boyd, D., et al., "Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines," Cancer Research, 48:3112-3116 (Jun. 1, 1988).
Boyd, D., et al., "Modulation of the urokinase receptor in human colon cell lines by N,N-dimethylformamide," Biochimica et Biophysica Acta, 947:96-100 (1988).
Burtin, P., et al., "Receptor for Plasmin on Human Carcinoma Cells," J. Nat'l. Cancer Inst., 80(10):762-765 (Jul. 20, 1988).
Cubeilis, M.V., et al., "Binding of Single-chain Prourokinase to the Urokinase Receptor of Human U937 Cells," J. Biol. Chem., 26(34):15819-15822, (Dec. 1986).
Dan.o slashed., K., et al., "Plasminogen Activators, Tissue Degradation, and Cancer," Advances in Cancer Research, 41:140-264, (1985).
Dan.o slashed., K., et al., "Plasminogen Activators and Neoplasia," Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects, Kluft, ed., CRC Press, Boca Raton, pp. 19-46 (1988).
Ellis, V., et al., "Role of human U937 monocytes in controlling single-chain urokinase-initiated plasminogen activation," Fibrinolysis, 2:112 (1988).
Ellis, V., et al., "Plasminogen Activation Initiated by a Single-Chain Urokinase-ytpe Plasminogen Activator," J. Biol. Chem., 264:2185-2188, (1988).
Estreicher, A., et al., "Characterization of the Cellular Binding Site for the Urokinase-Type Plasminogen Activator," J. Biol. Chem., 264(2):1180-1189, (Jan. 1989).
Hearing, V.J., et al., "Modulation of Metastatic Potential by Cell Surface Urokinase of Murine Melanoma Cells," Cancer Research, 48:1270-1278, (Mar., 1988).
Hebert, C.A., et al., "Linkage of Extracellular Plasminogen Activator to the Fibroblast Cystoskeleton: Colocalization of Cell Surface Urokinase with Vinculin," J. Cell Biol., 106:1241-1247, (Apr., 1987).
Mignatti, P., et al., "Tumor Invasion through the Human Amniotic Membrane: Requirement for a Proteinase Cascade," Cell, 47:487-498 (Nov. 1986).
Miles, L.A., et al., "Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells," Thrombosis and Haemostasis, 58(3):936-942 (1987).
Needham, G.K., et al., "Binding of urokinase to specific receptor sites on human breast cancer membranes," Br. J. Cancer, 55:13-16 (1987).
Nelles, L., et al., "Characterization of Recombinant Human Single Chain Urokinase-type Plasminogen Activator Mutants Produced by Site-specific Mutagenesis of Lysine 158," J. Biol. Chem., 262(12):5682-89, (1987).
Nielsen, L.S., et al., "A 55,000-60,000, M.sub.r Receptor Protein for Urokinase-type Plasminogen Activator," J. Biol. Chem., 263(5):2358-2363, (Feb. 1988).
Ossowski, L., "Plasminogen Activator Dependent Pathways in the Dissemination of Human Tumor Cells in the Chick Embryo," Cell, 52:321-328 (Feb. 1988).
Ossowski, L., et al., "Antibodies to Plasminogen Activator Inhibit Human Tumor Metastasis," Cell, 35:611-619 (Dec. 1983).
Pannell, R., et al., "Activation of Plasminogen by Single-Chain Urokinase or by Two-Chain Urokinase--A Demonstration That Single-Chain Urokinase Has A Low . . . ," Blood, 69(1):22-26 (Jan. 1987).
Petersen, L.C., et al., "One-chain Urokinase-type Plasminogen Activator from Human Sarcoma Cells Is a Proenzyme with Little or No Intrinsic Activity," J. Biol. Chem., 263(23):11189-11195, (Aug. 1988).
Picone, R., et al., "Regulation of Urokinase Receptors in Monocyte-Like U937 Cells by Phorbol Ester PMA," J. Cell Biol., 1989.
Plow, E.F., et al., "The Plasminogen System and Cell Surfaces: Evidence for Plasminogen and Urokinase Receptors on the Same Cell Type," J. Cell Biol., 103(6):2411-2420 (Dec. 1986).
Pollanen, J., et al., "Ultrastructural Localization of Plasma Membrane-associated Urokinase-type Plasminogen Activator at Focal Contacts," J. Cell Biol., 106:87-95, (Jan. 1988).
Pollanen, J., et al., "Distinct Localizations of Urokinase-type Plasminogen Activator and Its Type 1 Inhibit- or under Cultured Human Fibroblasts and Sarcoma Cells," J. Cell Biol., 104:1085-1096, (Apr. 1987).
Reich, R., et al., "Effects of Inhibitors of Plasminogen Activator, Serine Proteinase, and Collagenases IV on the Invasion of Basement Membranes by Metastatic Cells," Cancer Research, 48:3307-3312, (Jun. 1988).
Saksela, O., "Plasminogen activation and regulation of pericellular proteolysis," Biochimica et Biophysica Acta, 823:35-65, (1985).
Skriver, L., et al., "Immunocytochemical Localization of Urokinase-type Plasminogen Activator in Lewis Lung Carcinoma," J. Cell Biol., 99:752-757, (Aug. 1984).
Stoppelli, M.P., et al., "Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes," Proc. Natl. Acad. Sci. USA, 82:4939-43, 1985.
Stoppelli, M.P., et al., "Autocrine Saturation of Pro-Urokinase Receptors on Human A431 Cells," Cell 45: 675-684, (Jun. 1986).
Vassalli, J., et al., "A Cellular Binding Site for the M.sub.r 55,000 Form of the Human Plasminogen Activator, Urokinase," J. Cell. Biol., 100:86-92, (Jan. 1985).
Appella Ettore
Behrendt Niels
Blasi Francesco
Cubellis Maria Vittoria
Dan.o slashed. Keld
Cancerforskningsfondet af 1989
Cooper Iver P.
Fitzgerald David L.
Walsh Stephen G.
LandOfFree
Vectors and methods for recombinant production of uPA-binding fr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors and methods for recombinant production of uPA-binding fr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors and methods for recombinant production of uPA-binding fr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1370261